tag accelerated-development 
European Pharmaceutical Review
APRIL 19, 2023
Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified. The COVID-19 pandemic accelerated the adoption and use of wireless ID.
PM360
NOVEMBER 27, 2023
The first solution, developed by EVERSANA leveraging AWS and AWS Partner TensorIoT , addresses a time-consuming and error-prone process in the industry—medical and regulatory content approvals. The new offering is the first of several new EVERSANA solutions in development leveraging AWS.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PM360
OCTOBER 13, 2023
Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. Auto-tagging ensures that the right content efficiently reaches the right customers. Fine-tuning models can target domains and generate prompts to tag the content into relevant topics.
PM360
JUNE 26, 2023
Accelerated Content Creation and Organization Personalized engagement is crucial for successful commercialization, especially as more physicians have come to expect it from their online interactions as consumers. Auto-tagging, a laborious task, is another area where generative AI/LLMs can assist.
Pharmaceutical Technology
MAY 15, 2023
Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity. The company develops drugs and diagnostics to treat major diseases.
PM360
APRIL 22, 2024
From defining the target product profile to shaping clinical endpoints and devising asset strategies to crafting scientific narratives, the value of Medical Affairs permeates every aspect of product development. An honest understanding of Medical Affairs situations and needs will be essential to ensure data-driven decision-making.
Pharmaceutical Technology
JUNE 29, 2022
This year has already been eventful when it comes to the development of therapies for rare diseases. Most, if not all, of these therapies used the FDA’s Orphan Drug Designation to aid their development plans. Additionally, pricing and access for rare disease therapies continue to be scrutinized closely.
Expert insights. Personalized for you.
84 
Let's personalize your content